chronic conditions
The startup provides an app that rewards patients for completing health behaviors like taking medications or monitoring blood pressure.
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
The addition comes weeks after Omada Health announced a $192 million Series E financing round.
The agreement also allows the companies to develop new or improved tools for Dario's chronic condition management platform.
The virtual care giant said the latest offering was accelerated by its merger with Livongo in 2020.
Biofourmis Care currently includes programs for heart failure, hypertension, diabetes, lipid management and atrial fibrillation.
The virtual care company plans to add devices that can transmit metrics like blood pressure or glucose levels to MDLIVE's patient portal later this year.
2022 Look Ahead
Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue this year, and that the push toward interoperability will be critical for the space.
2022 Look Ahead
After another rough year for the healthcare system, startups are using the growth of virtual care to manage chronic conditions and expand primary care.
The company emerged from stealth in August with $41 million.